OREXO AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.24 SEK | +6.05% |
|
+10.28% | +17.98% |
| 04-17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
| 04-17 | Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US | CI |
Chart calendar Orexo AB
bd912af44e33.q2D7WVTlJC_COomwzVnhUY6dhnia4biqpV6RbzeHOv0.xi6KbB-sEHX3ecvmohiJAObUzyfOrs3rwSSgN3L1Xsz5L6IDYdB9aYtxzA~559dd40e4c9c1fb075675c4482c80cad
Upcoming events on Orexo AB
Past events on Orexo AB
| 26/04/2024 15:00 | Annual General Meeting |
| 04/03/2024 | Carnegie Healthcare Conference |
| 08/02/2024 13:00 | Q4 2023 Earnings Call |
| 08/02/2024 07:23 | Q4 2023 Earnings Release |
| 02/11/2023 13:00 | Q3 2023 Earnings Call |
| 02/11/2023 07:22 | Q3 2023 Earnings Release |
| 26/10/2023 14:00 | Extraordinary Shareholders Meeting |
| 13/09/2023 | Pareto Securities' Healthcare Conference |
| 18/07/2023 14:00 | Q2 2023 Earnings Call |
| 18/07/2023 07:00 | Q2 2023 Earnings Release |
| 22/06/2023 14:30 | OTC Life Science Investor Forum |
| 30/05/2023 | ABG Sundal Collier Life Science Summit |
| 27/04/2023 13:00 | Q1 2023 Earnings Call |
| 27/04/2023 07:33 | Q1 2023 Earnings Release |
| 18/04/2023 15:00 | Annual General Meeting |
| 07/03/2023 | Stockholm Corporate Finance Life Science Days |
| 26/01/2023 13:00 | FY 2022 Earnings Call |
| 26/01/2023 07:25 | FY 2022 Earnings Release |
| 08/01/2023 | J.P. Morgan Healthcare Conference |
| 15/12/2022 14:30 | OTC Markets Group KCSA Mental Health Investor Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 845 849 -0.44% | 664 660 0.53% | 565 566 -0.23% | 624 628 -0.52% | 639 627 1.89% | 617 |
|
EBITDA Million SEK | Released Forecast Spread | 272 278 -2.11% | 19,0 -70,5 126.93% | -161 -151 -6.53% | -115 -74,3 -55.1% | -32,5 -59,3 45.21% | 18,9 |
|
EBIT Million SEK | Released Forecast Spread | 231 253 -8.45% | -19,9 -98,8 79.86% | -214 -190 -12.68% | -184 -182 -0.98% | -110 -121 9.63% | -66,2 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 228 278 -17.96% | -38,3 -90,2 57.52% | -223 -197 -13.19% | -170 -160 -6.82% | -140 -146 4.15% | -115 |
|
Net income Million SEK | Released Forecast Spread | 219 270 -18.94% | -84,4 -118 28.58% | -224 -197 -13.5% | -178 -170 -4.34% | -128 -122 -5.17% | -107 |
|
EPS SEK | Released Forecast Spread | 6,20 7,79 -20.4% | -2,45 -3,34 26.72% | -6,51 -5,73 -13.61% | -5,17 -4,93 -4.87% | -3,73 -3,55 -5.07% | -3,11 |
| Announcement Date | 30/01/20 | 28/01/21 | 27/01/22 | 26/01/23 | 08/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 144 148 -2.7% | 156 161 -3.04% | 159 153 4.13% | 158 154 2.54% | 156 154 1.17% | 166 161 2.85% | 144 | 156 | 157 | 160 | |
|
EBITDA Million SEK | Released Forecast Spread | -48,5 -36,0 -34.72% | -53,1 -51,6 -2.91% | -41,1 -54,5 24.59% | 5,60 -26,0 121.54% | -9,50 -4,60 -106.52% | 12,4 15,5 -20% | 6,30 | 2,10 | 5,00 | 5,50 | |
|
EBIT Million SEK | Released Forecast Spread | -64,1 -45,0 -42.44% | -71,1 -67,4 -5.49% | -59,3 -72,4 18.09% | -12,9 -44,2 70.81% | -28,6 -23,1 -23.81% | -8,60 -3,00 -186.67% | -14,9 | -19,2 | -16,3 | -15,8 | |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -95,5 -73,9 -29.23% | -68,5 -80,2 14.59% | -15,8 -53,7 70.58% | -36,6 -32,3 -13.31% | -19,5 -12,0 -62.5% | -27,4 | -31,7 | -28,3 | -27,3 | ||
|
Net income Million SEK | Released Forecast Spread | -66,0 -39,0 -69.23% | -26,5 | -91,8 -73,9 -24.22% | -63,9 -80,2 20.32% | -12,6 -53,7 76.54% | -33,3 -25,8 -29.07% | -18,6 -9,60 -93.75% | -26,6 | -29,8 | -26,0 | -24,5 |
|
EPS SEK | Released Forecast Spread | -1,92 -1,10 -74.55% | -0,77 | -2,67 -2,15 -24.19% | -1,86 -2,33 20.17% | -0,37 -0,92 59.78% | -0,97 -0,92 -5.43% | -0,54 -0,92 41.3% | -0,77 | -0,87 | -0,76 | -0,71 |
| Announcement Date | 27/01/22 | 03/11/22 | 26/01/23 | 27/04/23 | 18/07/23 | 02/11/23 | 08/02/24 | - | - | - | - |
More events
Past sector events for Orexo AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ORX Stock
- Calendar Orexo AB
